Grisnilimab (Anti-CD7)
Grisnilimab (Anti-CD7) (A2834-GRP)
Products
Description
Grisnilimab (Anti-CD7) is an IgG2a monoclonal antibody against CD7. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA. MW : 144.72 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2834 |
| Target | CD markers |